Afficher la notice abrégée

dc.rights.licenseopenen_US
hal.structure.identifierBordeaux population health [BPH]
hal.structure.identifierEpicentre [Paris] [Médecins Sans Frontières]
dc.contributor.authorBEN FARHAT, Jihane
hal.structure.identifierBordeaux population health [BPH]
hal.structure.identifierCentre Hospitalier Universitaire de Bordeaux [CHU Bordeaux]
dc.contributor.authorHESSAMFAR, Mojgan
hal.structure.identifierBordeaux population health [BPH]
hal.structure.identifierCentre Hospitalier Universitaire de Bordeaux [CHU Bordeaux]
dc.contributor.authorNEAU, Didier
hal.structure.identifierCentre Hospitalier de la Côte Basque [CHCB]
dc.contributor.authorFARBOS, Sophie
hal.structure.identifierCentre Hospitalier Universitaire de Bordeaux [CHU Bordeaux]
dc.contributor.authorLAZARO, Estibaliz
hal.structure.identifierImmunology from Concept and Experiments to Translation = Immunologie Conceptuelle, Expérimentale et Translationnelle [ImmunoConcept]
dc.contributor.authorDUFFAU, Pierre
hal.structure.identifierCENTRE HOSPITALIER PÉRIGUEUX [CHP]
dc.contributor.authorROUANES, Nicolas
hal.structure.identifierMicrobiologie Fondamentale et Pathogénicité [MFP]
dc.contributor.authorCAZANAVE, Charles
hal.structure.identifierBordeaux population health [BPH]
hal.structure.identifierCentre Hospitalier Universitaire de Bordeaux [CHU Bordeaux]
dc.contributor.authorPISTONE, Thierry
hal.structure.identifierCentre Hospitalier Agen-Nérac
dc.contributor.authorRISPAL, Patrick
hal.structure.identifierInstitut de Santé Publique, d'Epidémiologie et de Développement [ISPED]
hal.structure.identifierBordeaux population health [BPH]
hal.structure.identifierCentre Hospitalier Universitaire de Bordeaux [CHU Bordeaux]
dc.contributor.authorVANDENHENDE, Marie-Anne
hal.structure.identifierCentre Hospitalier Universitaire de Bordeaux [CHU Bordeaux]
dc.contributor.authorKRZYZANOWSKY, Camille
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorLELEUX, Olivier
hal.structure.identifierStatistics In System biology and Translational Medicine [SISTM]
hal.structure.identifierTeam MORPH3EUS [INSERM U1219 - UB - ISPED]
dc.contributor.authorWITTKOP, Linda
hal.structure.identifierBordeaux population health [BPH]
hal.structure.identifierHôpital Saint-André
hal.structure.identifierGlobal Health in the Global South [GHiGS]
dc.contributor.authorBONNET, Fabrice
hal.structure.identifierBordeaux population health [BPH]
hal.structure.identifierCentre Hospitalier Universitaire de Bordeaux [CHU Bordeaux]
hal.structure.identifierInstitut Pascal [IP]
dc.contributor.authorBARGER, Diana
dc.date.accessioned2025-01-16T08:53:21Z
dc.date.available2025-01-16T08:53:21Z
dc.date.issued2025-01-06
dc.identifier.issn1090-7165en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/204317
dc.description.abstractEnWe investigated people living with HIV (PLWH)'s exposure to COVID-19 pandemic stressors and their association with distress, psychological growth, and substance use. PLWH in the ANRS CO3 AQUIVIH-NA cohort's QuAliV study (Nouvelle Aquitaine, France) completed an adapted CAIR Lab Pandemic Impact Questionnaire (C-PIQ) and reported substance use between 9/2021 to 3/2022. We described cumulative stressor exposure (score 0-16) and explored variation by PLWH characteristics (demographic, HIV-related, risk factors, psychosocial). Associations with distress (score 0-23), psychological growth (score 0-20), and substance use were assessed using regression models. Participants reported exposure to a median of 2 (IQR: 1-4) stressors. Stressor exposure was higher in working-age (<60) and psychosocially vulnerable PLWH. Exposure to an additional stressor correlated with a 0.7-point increase in distress scores (95% C.I. 0.5-1.0, p<0.001), a 0.04-point increase (95% C.I. 0.01-0.07, p=0.002) in psychological growth scores in working-age PLWH. In older PLWH, additional stressor correlated with a 0.8-point (95% C.I. 0.4-1.2, p<0.001) increase in distress and a 0.1-point increase (95% C.I. 0.06-0.2, p=0.001) in growth scores. Each additional stressor was associated with 1.2 (95% C.I. 1.0-1.4, p=0.02) higher adjusted odds of cannabis use in working-age PLWH, and 1.2 (95% C.I. 1.0-1.4, p=0.004) higher adjusted odds of drug use. Exposure to stressors was linked to increased distress, cannabis and drug use but also growth. Providers should not only be aware of risk (of severe COVID-19) but also be mindful of the social and psychological challenges PLWH face as these may affect their retention in care, especially during challenging times.
dc.language.isoENen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/
dc.subject.enHIV
dc.subject.enCOVID-19
dc.subject.enDistress
dc.subject.enPsychological growth
dc.subject.enCannabis
dc.subject.enDrugs
dc.title.enExposure to COVID-19 Pandemic-Related Stressors and Their Association With Distress, Psychological Growth and Drug Use in People With HIV in Nouvelle Aquitaine, France (ANRS CO3 AQUIVIH-NA Cohort-QuAliV-QuAliCOV Study)
dc.typeArticle de revueen_US
dc.identifier.doi10.1007/s10461-024-04588-5en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed39757312en_US
bordeaux.journalAIDS and Behavioren_US
bordeaux.hal.laboratoriesMFP (Laboratoire Microbiologie Fondamentale et Pathogénicité) - UMR 5234en_US
bordeaux.institutionCNRSen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.import.sourcehal
hal.identifierhal-04871453
hal.version1
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exportfalse
workflow.import.sourcehal
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=AIDS%20and%20Behavior&rft.date=2025-01-06&rft.eissn=1090-7165&rft.issn=1090-7165&rft.au=BEN%20FARHAT,%20Jihane&HESSAMFAR,%20Mojgan&NEAU,%20Didier&FARBOS,%20Sophie&LAZARO,%20Estibaliz&rft.genre=article


Fichier(s) constituant ce document

Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée